Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

Journal of Experimental Medicine

Volumn 175, Issue 2, 1992, Pages 323-329

  Aderka, Dan ^a   Engelmann, Hartmut ^b   Maor, Yasmin ^a   Brakebusch, Cord ^b   Wallach, David ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ARTICLE; CELL GROWTH; FIBROBLAST; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

CELL COUNT; CELLS, CULTURED; CHROMATOGRAPHY, GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; HUMAN; KINETICS; LEUKEMIA, B-CELL, CHRONIC; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0026516744     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.175.2.323     Document Type: Article

References (35)

1. Beutler, B., and A. Cerami. 1988. Tumor necrosis, cachexia, shock and inflammation: a common mediator. Annu. Rev. Biochem. 57:505.
2. Old, L.J. 1989. Tumor necrosis factor. Sci. Am. 258:41.
3. Hohmann, H.P., R. Remy, M. Brockhaus, and A.P.G.M. van Loon. 1989. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J. Biol. Chem. 265:14497.
4. Engelmann, H., H. Holtmann, C. Brakebusch, Y. Shemer-Avni, I. Sarov, Y. Nophar, E. Hadas, O. Leitner, and D. Wallach. 1990. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol Chem. 265:14497.
5. Olsson, I., M. Lantz, E. Nilsson, C. Peetre, H. Thysell, and A. Grubb. 1989. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur. J. Haematol. 42:270.
6. Seckinger, P., S. Isaaz, and J.-M. Dayer. 1989. Purification and Biologic characterization of a specific tumor necrosis factor a inhibitor. J. Biol. Chem. 264:11966.
7. Engelmann, H., D. Aderka, M. Rubinstein, D. Rotman, and D. Wallach. 1989. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxity. J. Biol. Chem. 264:11974.
8. Engelmann, H., D. Novick, and D. Wallach. 1990. Two tumor-necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem. 265:1531.
9. Nophar, Y., O. Kemper, C. Brakebusch, H. Engelmann, R. Zwang, D. Aderka, H. Holtmann, and D. Wallach. 1990. Soluble forms of tumor necrosis factors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO(Eur. Mol. Biol. Organ.) J. 9:3269.
10. Smith, R.A., and C. Baglioni. 1987. The active form of tumor necrosis factor is a trimer. J. Biol. Chem. 262:6951.
11. Narhi, L.O., and T. Arakawa. 1987. Dissociation of recombinant tumor necrosis factor-a studied by gel permeation chromatography. Biochem. Biophys. Res. Commun. 147:740.
12. Jones, E.Y., D.I. Stuart, and N.P.C. Walker. 1989. Structure of tumor necrosis factor. Nature (Land.). 338:225.
13. Eck, M.Y., and S.R. Sprang. 1989. The structure of tumor necrosis factor-a at 2.6 Á resolution. Implications for receptor binding. J. Biol. Chem. 264:17595.
14. Israel, S., T. Hahn, H. Holtmann, and D. Wallach. 1986. Binding of human TNF-a to high-affinity cell surface receptors: effect of interferon. Immunol. Lett. 12:217.
15. Aderka, D., J. Le, and J.T. Vilcek. 1989. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells and in mice. J. Immunol. 143:3517.
16. Madsen, M., H.E. Johnsen, P. Wendelboe-Hanser, and S.E. Christiansen. 1980. Isolation of human B and T lymphocytes by E rosette gradient centrifugation. J. Immunol. Methods. 33:323.
17. Fischer, D.G., W.J. Hubbard, and H.S. Koren. 1981. Tumor cell killing by freshly isolated peripheral blood monocytes. Cell. Immunol. 58:426.
18. Weissenbach, J., M. Zeevi, T. Landau, and M. Revel. 1979. Identification of the translation products of human fibroblast interferon mRNA in reticulocyte lysates. Eur. J. Biochem. 98:1.
19. Littlefield, J.W. 1964. Three degrees of guanylic acid-inosinic acid pyrophosphorylase deficiency in mouse fibroblasts. Nature (bond.). 203:1142.
20. Wallach, D. 1984. Preparations of lymphotoxin induce resistance to their own cytotoxic effect. J. Immunol. 132:2464.
21. Aderka, D., H. Engelmann, V. Hornik, Y. Skornick, Y. Levo, D. Wallach, and G. Kustai. 1991. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res. 51:5602.
22. Cordingley, F.T., A.V. Hoffbrand, H.E. Heslop, M. Turner, A. Bianchi, J.E. Reittie, A. Vyakarnam, A. Meager, and A. Brenner. 1988. Tumor necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet. i:969.
23. Digel, W., M. Stefanie, W. Schöniger, C. Buck, A. Rag-havachar, N. Frickhofen, H. Heimpel, and F. Porzsolt. 1988. Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood. 73:1242.
24. Vilcek, T.J., V.J. Palombella, D. Henricksen-DeStefano, C. Swenson, R. Feinman, M. Hirai, and M. Tsujimoto. 1986. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J. Exp. Med. 163:632.
25. Munk Petersen, C., A. Nykjoer, B.S. Christiansen, L. Heick-enporff, S.C. Morgensen, and B. Moller. 1989. Bioactive human recombinant tumor necrosis factor-a: An unstable dimer? Eur. J. Immunol. 19:1887.
26. Beutler, B., I.W. Milsark, and A. Cerami. 1985. Cachectin/ tumor necrosis factor: production, distribution, and metabolic fate in vivo. J. Immunol. 135:3972.
27. Hopkins, S.J., and A. Meager. 1988. Cytokines in synovial fluid: II. The presence of tumor necrosis factor and interferon. Clin. Exp. Immunol. 73:88.
28. DiGiovine, F., G. Nuki, and G.W. Duff. 1988. Tumor necrosis factor in synovial exudates. Ann. Rheum. Dis. 47:768.
29. Ophir, D., T. Hahn, A. Schattner, D. Wallach, and A. Aviel. 1988. Tumor necrosis factor in middle ear effusions. Arch. Otolaryngol. 114:1256.
30. Waage, A., A. Haistensen, R. Shalaby, P. Brandtzaeg, P. Kieruff, and T. Espevik. 1989. Local production of tumor necrosis factor at, interleukin 1, and interleukin 6 in meningococcal meningitis. J. Exp Med. 170:1859.
31. Möller, B., S.C. Mogensen, P. Wendelboe, K. Bendtzen, and C.M. Petersen. 1991. Bioactive and inactive forms of tumor necrosis factor-a in spinal fluid from patients with meningitis. J. Infect. Dis. 163:886.
32. Nelson, S., G.J. Bagby, B.G. Bainton, L.A. Wilson, J.J. Thompson, and W.R. Summer. 1989. Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J. Infect. Dis. 159:189.
33. Bagby, G.J., K.J. Plessala, L.A. Wilson, J.J. Thompson, and S. Nelson. 1991. Divergent efficiency of antibody to tumor necrosis factor-a in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163:83.
34. Johnson, J.D., M.L. Wong, and W.J. Rutter. 1989. Properties of the insulin receptor ectodomain. Proc Natl. Acad. Sci. USA. 85:7516.
35. Greenfield, C., I. Hiles, M.D. Waterfield, M. Federwisch, A. Wollmer, T.L. Blundell, and N. McDonald. 1989. Epidermal growth factor binding induces a conformational change in the external domain of its receptor. EMBO (Eur. Mol. Biol. Organ.) J. 8:4115.